Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Francisco Rocha-Goncalves"'
Autor:
Anke Wind, Joris van Dijk, Isabelle Nefkens, Wineke van Lent, Péter Nagy, Ernestas Janulionis, Tuula Helander, Francisco Rocha-Goncalves, Wim van Harten
Publikováno v:
BMC Health Services Research, Vol 18, Iss 1, Pp 1-14 (2018)
Abstract Background Differences in cancer survival exist between countries in Europe. Benchmarking of good practices can assist cancer centers to improve their services aiming for reduced inequalities. The aim of the BENCH-CAN project was to develop
Externí odkaz:
https://doaj.org/article/c367eeaf979746bfbb8f725da2ed1d54
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Joaquim A. Meireles-Brandão, Lúcia R. Meireles-Brandão, Rui Coelho, Francisco Rocha-Gonçalves
Publikováno v:
Revista Portuguesa de Cardiologia, Vol 41, Iss 8, Pp 681-688 (2022)
Introduction and Objectives: Lifestyle changes are frequently insufficient to reduce cardiovascular (CV) risk in patients with dyslipidemia. This study aims to characterize the long-term evolution of lipid profile and CV risk of patients under primar
Externí odkaz:
https://doaj.org/article/d70c89f840934b9ead9293b7b2f30ed0
Autor:
Cristina Gavina, Inês Falcão-Pires, João Santos-Faria, Benjamim Marinho, Jorge Almeida, João Rodrigues, Paulo Pinho, Francisco Rocha-Gonçalves, Adelino Leite-Moreira
Publikováno v:
Revista Portuguesa de Cardiologia, Vol 41, Iss 1, Pp 3-14 (2022)
Introduction and objectives: Among patients with aortic stenosis (AS), interstitial fibrosis has been associated with progression to heart failure and is a marker of poorer prognosis. We aimed to assess the impact of myocardial fibrosis on clinical e
Externí odkaz:
https://doaj.org/article/0f34a7f648134ffe816fd0bd86e219a0
Autor:
Andreia Borges, Filipa Pereira, Patrícia Redondo, Luís Antunes, Cláudia Vieira, Pedro Antunes, Maria José Bento, Susana Sousa, José Machado Lopes, Francisco Rocha-Gonçalves, Joaquim Abreu de Sousa, Deolinda Sousa Pereira, Marina Borges
Publikováno v:
Health Economics Review, Vol 11, Iss 1, Pp 1-13 (2021)
Highlights i. The results obtained in the AC-DHP cohort, which included Pertuzumab as a NeoT, suggest better clinical outcomes compared to the AC-DH group, a confirmation based on real-world data. ii. Some patient profiles seem to be more promising c
Externí odkaz:
https://doaj.org/article/c09cb8f7d2b142abb81bf3f39656212d
Publikováno v:
Global Journal on Quality and Safety in Healthcare, Pp 65-68 (2020)
At present, for patients with metastatic and castration-resistant prostate cancer, European Society for Medical Oncology and National Comprehensive Cancer Network guidelines recommend enzalutamide (E) or abiraterone (A). There are still a few studies
Externí odkaz:
https://doaj.org/article/d6d72225cd664d78a35b187df3811ab7
Autor:
Francisco Rocha-Gonçalves
Publikováno v:
Global Journal on Quality and Safety in Healthcare, Pp 81-85 (2020)
Externí odkaz:
https://doaj.org/article/c6e79caf9b23425eb014a98ac8469a57
Publikováno v:
Global Journal on Quality and Safety in Healthcare, Pp 69-71 (2020)
Therapeutic drug monitoring (TDM) has as its main objective to ensure that the plasma drug concentration remains within the appropriate range. Regarding the economic dimension of TDM, it is known that there are gains in health outcomes; however, ther
Externí odkaz:
https://doaj.org/article/441e6d880ce545548dd19e48f9ac77c3